Changchun BCHT Biotechnology Co. (688276.SS)
CNY 26.21
(-0.53%)
CNY 26.21
(-0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.81 Billion | 1.07 Billion | 1.2 Billion | 1.44 Billion | 975.66 Million | 1.01 Billion |
| Cost of Revenue | 210.35 Million | 137.22 Million | 140.75 Million | 168.42 Million | 93.88 Million | 112.63 Million |
| Gross Profit | 1.6 Billion | 934.22 Million | 1.06 Billion | 1.27 Billion | 881.77 Million | 906.28 Million |
| Operating Expenses | 1.08 Billion | 692.75 Million | 716.46 Million | 794.28 Million | 601.03 Million | 740.61 Million |
| Selling, General and Administrative Expenses | 850.81 Million | 471.28 Million | 481.32 Million | 594.7 Million | 469.51 Million | 622.12 Million |
| Research and Development Expenses | 208.73 Million | 133.52 Million | 156.76 Million | 93.36 Million | 65.16 Million | 61.79 Million |
| Other Expenses | -14.95 Million | 87.94 Million | 78.37 Million | 106.21 Million | 66.36 Million | 385.16 Thousand |
| Cost and Expenses | 1.26 Billion | 829.98 Million | 857.21 Million | 962.71 Million | 694.92 Million | 853.24 Million |
| Operating Income | 559.29 Million | 272.66 Million | 354.92 Million | 482.16 Million | 267.88 Million | 149.42 Million |
| Interest Expense | 868.14 Thousand | 74.97 Million | 328.77 Thousand | 4.04 Million | 8.29 Million | 9.42 Million |
| Income Tax Expense | 62.74 Million | 16.15 Million | 18.01 Million | 68.41 Million | 42.81 Million | 21.75 Million |
| Earnings before Tax | 563.75 Million | 197.69 Million | 261.56 Million | 486.65 Million | 263.83 Million | 149.81 Million |
| Net Income | 501 Million | 181.53 Million | 243.55 Million | 418.23 Million | 221.02 Million | 128.05 Million |
| Earnings Per Share Basic | 1.21 | 0.44 | 0.59 | 1.01 | 0.54 | 0.36 |
| Earnings Per Share Diluted | 1.21 | 0.44 | 0.59 | 1.01 | 0.54 | 0.36 |
| Weighted Average Shares Outstanding | 414.05 Million | 412.84 Million | 412.84 Million | 412.84 Million | 412.84 Million | 355.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 414.05 Million | 412.84 Million | 412.84 Million | 412.84 Million | 412.84 Million | 355.71 Million |
| Gross Margin | 0.88 | 0.87 | 0.88 | 0.88 | 0.90 | 0.89 |
| EBIT Margin | 0.37 | 0.32 | 0.35 | 0.38 | 0.31 | 0.19 |
| Profit Margin | 0.28 | 0.17 | 0.20 | 0.29 | 0.23 | 0.13 |
| EBITDA | 662.93 Million | 274.15 Million | 332.4 Million | 546.13 Million | 329.03 Million | 194.48 Million |
| Earnings Before Tax Margin | 0.31 | 0.25 | 0.30 | 0.33 | 0.27 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 407.61 Million | 345.51 Million | 268.05 Million | 1.81 Billion | 577.43 Million | 683.54 Million |
| Cost of Revenue | 74.06 Million | 56.79 Million | 27.79 Million | 213.34 Million | 47.99 Million | 71.89 Million |
| Gross Profit | 333.55 Million | 288.71 Million | 240.26 Million | 1.59 Billion | 529.43 Million | 611.65 Million |
| Operating Expenses | 198.36 Million | 197.17 Million | 178.74 Million | 1.05 Billion | 343.79 Million | 331.89 Million |
| Selling, General and Administrative Expenses | 219.24 Million | 174.56 Million | 131.8 Million | - | 246.56 Million | 323.66 Million |
| Research and Development Expenses | 30.97 Million | 32.7 Million | 46.94 Million | - | 56.2 Million | 50.08 Million |
| Other Expenses | -51.85 Million | 10.1 Million | -131.01 Thousand | -26.55 Million | -41.02 Million | -685.44 Thousand |
| Cost and Expenses | 272.42 Million | 253.97 Million | 206.53 Million | 1.26 Billion | 391.79 Million | 403.78 Million |
| Operating Income | 125.14 Million | 91.54 Million | 61.51 Million | 541.91 Million | 185.63 Million | 255.05 Million |
| Interest Expense | 429.32 Thousand | 382.95 Thousand | 499.12 Thousand | 868.14 Thousand | 148.34 Thousand | 292.68 Thousand |
| Income Tax Expense | 13.76 Million | 17.64 Million | 3.56 Million | 62.74 Million | 20.35 Million | 34.66 Million |
| Earnings before Tax | 120.53 Million | 94.72 Million | 63.86 Million | 563.06 Million | 190.04 Million | 254.37 Million |
| Net Income | 106.76 Million | 77.03 Million | 60.56 Million | 501 Million | 169.91 Million | 219.7 Million |
| Earnings Per Share Basic | 0.26 | 0.19 | 0.15 | - | 0.41 | 0.53 |
| Earnings Per Share Diluted | 0.26 | 0.19 | 0.15 | - | 0.41 | 0.53 |
| Weighted Average Shares Outstanding | 413.65 Million | 413.65 Million | 412.84 Million | 412.84 Million | 412.84 Million | 412.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 413.65 Million | 413.65 Million | 412.84 Million | 412.84 Million | 412.84 Million | 412.84 Million |
| Gross Margin | 0.82 | 0.84 | 0.90 | 0.88 | 0.92 | 0.89 |
| EBIT Margin | 0.30 | 0.37 | 0.23 | - | 0.36 | 0.41 |
| Profit Margin | 0.26 | 0.22 | 0.23 | 0.28 | 0.29 | 0.32 |
| EBITDA | 120.96 Million | 127.48 Million | 61.24 Million | - | 209.38 Million | 281.65 Million |
| Earnings Before Tax Margin | 0.31 | 0.26 | 0.23 | 0.30 | 0.32 | 0.37 |
KIERF
005930
KRRO
300331
TRST
ATRO